Estados Unidos · Plataformas y datos · Yahoo Finance

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

Publicado por Yahoo Finance · Estados Unidos hace 8 h

Pfizer (NYSE:PFE) signed a new research collaboration and license agreement with Enodia Therapeutics to develop Sec61 inhibitors. The arrangement centers on small-molecule Sec61…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

También te puede interesar

Financial Institutions (FISI) Set to Release Quarterly Earnings on Thursday

IBM expects 2026 revenue growth of 4% to 5% while raising free cash flow growth view to more than $1B

Is This Cryptocurrency a Potential Millionaire-Maker?

My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now?

Nokia reports 9% Q3 sales growth, raises restructuring costs

SPCX Stock Eyes Best Week In Nearly 3 Months — But Analyst Warns Investors May Have To ‘Wait Decades’ To Justify Its Valuation

Pfizer (PFE) Signs New Drug Discovery Pact Focused On Sec61 Inhibitors

Compartir

También te puede interesar

Financial Institutions (FISI) Set to Release Quarterly Earnings on Thursday

IBM expects 2026 revenue growth of 4% to 5% while raising free cash flow growth view to more than $1B

Is This Cryptocurrency a Potential Millionaire-Maker?

My father-in-law, 81, sold his $75,000 home and paid off his daughter’s $50,000 debt. What happens to him now?

Nokia reports 9% Q3 sales growth, raises restructuring costs

SPCX Stock Eyes Best Week In Nearly 3 Months — But Analyst Warns Investors May Have To ‘Wait Decades’ To Justify Its Valuation